ICF Receives $31M Health Surveillance Contract From CDC

The U.S. Centers for Disease Control and Prevention (CDC) recently awarded global consulting and digital services provider ICF (NASDAQ:ICFI) a $31 million recompete contract to provide development, operations and maintenance support to the agency’s nationwide syndromic surveillance platform, BioSense. The contract has a term of four years, including a one-year base and three one-year options.